An interventional study of D-chiro-inositol in Functional Hypogonadism, sponsored by Cardarelli Hospital. Not yet recruiting. Open to male participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-05-13.
Sponsored by Cardarelli Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A prospective, uncontrolled, non-pharmacological interventional study conducted on men with functional or borderline hypogonadism, aimed at evaluating, after 3 months of supplementation with D-Chiro-inositol, changes in hormonal profile and sexual function.
The study involves the recruitment of 35 functional hypogonadal patients aged between 50 and 75 years to the Andrology Unit of the "Antonio Cardarelli" Hospital. At T0 patients will undergo hematochemical evaluation of the following parameters: total and free testosterone, PSA and hematocrit.
At the same time, they will be provided with a self-assessment questionnaire on physical and sexual functioning. The same evaluations will be performed after 3 months of supplementation (T1).
The main endpoint is the intra-subject variation in total and free testosterone levels between T0 and T1.
320 studies on the registry are indexed under Hypogonadism; 39 are open to participants now.
This study's planned enrollment of 35 is below the median of 50 across 243 interventional studies indexed under Hypogonadism.
Browse Hypogonadism studies →Cardarelli Hospital is the lead sponsor of 9 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Treatment with D-chiro-inositol
Dietary Supplement: D-chiro-inositol
Treatment with D-chiro-inositol (capsule) for 3 months 600 mg/2 die
Testosterone levels
Variation of serum testosterone levels
Time frame: From enrollment to three months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jul 2026; primary completion for Nov 2026, 4 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Chiro-inositol, (+)-
Cardarelli Hospital